Teva Pharmaceutical Industries (TEVA) EV to CFO (2009 - 2026)
Teva Pharmaceutical Industries' EV to CFO came in at 18.88 for Q2 2026, up 53.7% from 12.28 a year earlier and up 3.3% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) EV to CFO (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Teva Pharmaceutical Industries reported EV to CFO of 13.87, up 120.2% year-over-year; for FY2025, it was 22.45, up 19.2% from FY2024.
- EV to CFO has increased in each of the last three years.
- Going back by year, EV to CFO was 18.84 in FY2024 (+159.7%), 7.25 in FY2023 (+29.0%), 5.62 in FY2022 (-46.7%) and 10.54 in FY2021 (+22.8%).
- The five-year range for quarterly EV to CFO is 3.79 (Q2 2023) to 22.45 (Q4 2025).
- Year-over-year, EV to CFO has increased for four consecutive quarters, with growth averaging 52.3% over the last eight quarters.
- The fastest year-over-year change in EV to CFO over five years came in Q2 2024 (growth of 269.4%), and the weakest in Q2 2022 (a decline of 68.1%).
- Business Quant data shows TEVA's EV to CFO at 18.28 (Q1 2026), 22.45 (Q4 2025) and 19.68 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn |
| 10 | Teva Pharmaceutical Industries | 48.14 Bn | 34.98 Bn | 2.15 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.88 |
| Mar 31, 2026 | 18.28 |
| Dec 31, 2025 | 22.45 |
| Sep 30, 2025 | 19.68 |
| Jun 30, 2025 | 12.28 |
| Mar 31, 2025 | 12.59 |
| Dec 31, 2024 | 18.84 |
| Sep 30, 2024 | 9.38 |
| Jun 30, 2024 | 14.00 |
| Mar 31, 2024 | 9.54 |
| Dec 31, 2023 | 7.25 |
| Sep 30, 2023 | 8.44 |
| Jun 30, 2023 | 3.79 |
| Mar 31, 2023 | 5.71 |
| Dec 31, 2022 | 5.62 |
| Sep 30, 2022 | 6.98 |
| Jun 30, 2022 | 6.69 |
| Mar 31, 2022 | 7.94 |
| Dec 31, 2021 | 10.54 |
| Sep 30, 2021 | 14.39 |
API Access
Teva Pharmaceutical Industries EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();